Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETD1A MECOM PRDM2 SETBP1 DOT1L	1.07e-05	44	133	5	GO:0140938
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	SETD1A MECOM PRDM2 SETBP1 DOT1L	9.05e-05	68	133	5	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	SETD1A MECOM PRDM2 SETBP1 DOT1L	9.71e-05	69	133	5	GO:0016278
GeneOntologyMolecularFunction	histone methyltransferase activity	SETD1A MECOM PRDM2 SETBP1 DOT1L	1.11e-04	71	133	5	GO:0042054
GeneOntologyMolecularFunction	inositol 1,4,5-trisphosphate-gated calcium channel activity	ITPR2 ITPR3	1.32e-04	3	133	2	GO:0005220
GeneOntologyMolecularFunction	protein methyltransferase activity	SETD1A MECOM PRDM2 SETBP1 DOT1L	6.31e-04	103	133	5	GO:0008276
GeneOntologyMolecularFunction	N-methyltransferase activity	SETD1A MECOM PRDM2 SETBP1 DOT1L	6.89e-04	105	133	5	GO:0008170
GeneOntologyMolecularFunction	transferase activity, transferring one-carbon groups	SETD1A CAD MECOM PRDM2 PRDM10 SETBP1 DOT1L	7.66e-04	224	133	7	GO:0016741
GeneOntologyMolecularFunction	histone modifying activity	SETD1A KAT6A MECOM PRDM2 SETBP1 DOT1L HR	8.72e-04	229	133	7	GO:0140993
MousePheno	intervertebral disk degeneration	MECOM NFIX TP63	9.32e-06	6	110	3	MP:0004684
Domain	EGF	FRAS1 BRINP3 CNTNAP5 CELSR2 SUSD1 VCAN TENM1 NID1 MUC3A	4.24e-05	235	131	9	SM00181
Domain	DUF3697_Uba2	UBAP2 UBAP2L	4.88e-05	2	131	2	IPR022166
Domain	DUF3697	UBAP2 UBAP2L	4.88e-05	2	131	2	PF12478
Domain	EGF-like_dom	FRAS1 CNTNAP5 HMCN2 CELSR2 SUSD1 VCAN TENM1 NID1 MUC3A	6.63e-05	249	131	9	IPR000742
Domain	EGF_1	CNTNAP5 HMCN2 CELSR2 SUSD1 VCAN TENM1 NID1 USH2A MUC3A	7.96e-05	255	131	9	PS00022
Domain	InsP3_rcpt-bd	ITPR2 ITPR3	1.46e-04	3	131	2	IPR000493
Domain	AT_hook	ZBTB24 SETBP1 DOT1L	1.77e-04	16	131	3	PF02178
Domain	EGF_3	CNTNAP5 HMCN2 CELSR2 SUSD1 VCAN TENM1 NID1 MUC3A	2.56e-04	235	131	8	PS50026
Domain	G2F	HMCN2 NID1	2.90e-04	4	131	2	PF07474
Domain	NIDOGEN_G2	HMCN2 NID1	2.90e-04	4	131	2	PS50993
Domain	GFP	HMCN2 NID1	2.90e-04	4	131	2	IPR009017
Domain	G2_nidogen/fibulin_G2F	HMCN2 NID1	2.90e-04	4	131	2	IPR006605
Domain	-	ADGRG4 CNTNAP5 CELSR2 WDFY3 USH2A	5.50e-04	95	131	5	2.60.120.200
Domain	EGF_2	CNTNAP5 HMCN2 CELSR2 SUSD1 VCAN TENM1 NID1 MUC3A	5.69e-04	265	131	8	PS01186
Domain	ASX_HYDROXYL	HMCN2 CELSR2 SUSD1 VCAN NID1	6.95e-04	100	131	5	PS00010
Domain	RIH_assoc-dom	ITPR2 ITPR3	7.19e-04	6	131	2	IPR013662
Domain	Ins145_P3_rec	ITPR2 ITPR3	7.19e-04	6	131	2	PF08709
Domain	RIH_assoc	ITPR2 ITPR3	7.19e-04	6	131	2	PF08454
Domain	RIH_dom	ITPR2 ITPR3	7.19e-04	6	131	2	IPR000699
Domain	Ins145_P3_rcpt	ITPR2 ITPR3	7.19e-04	6	131	2	IPR014821
Domain	Ryanodine_recept-rel	ITPR2 ITPR3	7.19e-04	6	131	2	IPR015925
Domain	-	ITPR2 ITPR3	7.19e-04	6	131	2	1.25.10.30
Domain	RYDR_ITPR	ITPR2 ITPR3	7.19e-04	6	131	2	PF01365
Domain	Growth_fac_rcpt_	FRAS1 BRINP3 HMCN2 CELSR2 SUSD1 NID1	8.17e-04	156	131	6	IPR009030
Domain	AT_hook	ZBTB24 SETBP1 DOT1L	8.72e-04	27	131	3	SM00384
Domain	AT_hook_DNA-bd_motif	ZBTB24 SETBP1 DOT1L	8.72e-04	27	131	3	IPR017956
Domain	EGF-type_Asp/Asn_hydroxyl_site	HMCN2 CELSR2 SUSD1 VCAN NID1	9.05e-04	106	131	5	IPR000152
Domain	HMGI/Y_DNA-bd_CS	ZBTB24 SETBP1 DOT1L	1.31e-03	31	131	3	IPR000637
Domain	EGF_CA	HMCN2 CELSR2 SUSD1 VCAN NID1	1.69e-03	122	131	5	SM00179
Domain	EGF-like_Ca-bd_dom	HMCN2 CELSR2 SUSD1 VCAN NID1	1.82e-03	124	131	5	IPR001881
Domain	MIR	ITPR2 ITPR3	2.12e-03	10	131	2	PF02815
Domain	MIR_motif	ITPR2 ITPR3	2.12e-03	10	131	2	IPR016093
Domain	MIR	ITPR2 ITPR3	2.12e-03	10	131	2	PS50919
Domain	MIR	ITPR2 ITPR3	2.12e-03	10	131	2	SM00472
Domain	LAM_G_DOMAIN	CNTNAP5 CELSR2 USH2A	2.38e-03	38	131	3	PS50025
Domain	EGF-like_CS	HMCN2 CELSR2 SUSD1 VCAN TENM1 NID1 MUC3A	2.47e-03	261	131	7	IPR013032
Domain	GFP-like	SUSD1 NID1	2.58e-03	11	131	2	IPR023413
Domain	-	SUSD1 NID1	2.58e-03	11	131	2	2.40.155.10
Domain	Laminin_G_2	CNTNAP5 CELSR2 USH2A	2.76e-03	40	131	3	PF02210
Domain	-	MARF1 GEN1	3.08e-03	12	131	2	3.40.50.1010
Domain	LamG	CNTNAP5 CELSR2 USH2A	3.62e-03	44	131	3	SM00282
Domain	SEA	MUC16 MUC3A	4.20e-03	14	131	2	SM00200
Domain	PIN_domain-like	MARF1 GEN1	4.20e-03	14	131	2	IPR029060
Domain	PI3/4_kinase_CS	SMG1 PIK3C2G	4.83e-03	15	131	2	IPR018936
Domain	EGF_Ca-bd_CS	HMCN2 SUSD1 VCAN NID1	4.84e-03	97	131	4	IPR018097
Domain	SET_dom	SETD1A PRDM2 PRDM10	5.20e-03	50	131	3	IPR001214
Domain	SET	SETD1A PRDM2 PRDM10	5.20e-03	50	131	3	PS50280
Domain	EGF_CA	HMCN2 SUSD1 VCAN NID1	5.21e-03	99	131	4	PS01187
Domain	-	SMG1 PIK3C2G	5.49e-03	16	131	2	1.10.1070.11
Domain	PI3Kc	SMG1 PIK3C2G	5.49e-03	16	131	2	SM00146
Domain	PI3_PI4_kinase	SMG1 PIK3C2G	6.94e-03	18	131	2	PF00454
Domain	PI3_4_KINASE_1	SMG1 PIK3C2G	6.94e-03	18	131	2	PS00915
Domain	PI3_4_KINASE_2	SMG1 PIK3C2G	6.94e-03	18	131	2	PS00916
Domain	PI3/4_kinase_cat_dom	SMG1 PIK3C2G	6.94e-03	18	131	2	IPR000403
Domain	PI3_4_KINASE_3	SMG1 PIK3C2G	6.94e-03	18	131	2	PS50290
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SETD1A CAD UBAP2 MAP4 BAG3 MED1 PHGDH LUZP1 UBAP2L LPP XRN1 NUMB CLINT1 DOT1L SAP130 RPAP2	4.91e-10	549	135	16	38280479
Pubmed	Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.	ATMIN SMG1 MBNL1 ZBTB24 HSPA12A SETBP1 MARF1	1.31e-09	52	135	7	9455477
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DMTF1 SETD1A UBAP2 NUP214 MLLT10 POM121 KLF5 TP63 SETBP1 NUMB CLINT1 SAP130 SOS1	1.47e-08	430	135	13	35044719
Pubmed	Human transcription factor protein interaction networks.	FLG SMG1 SETD1A CAD UBAP2 MBNL1 HIPK2 MECOM NUP214 MLLT10 PRDM2 FHAD1 UBAP2L NFIX KLF5 SVIL EPC1 XRN1 MARF1 DOT1L SAP130 FBXW7	3.41e-08	1429	135	22	35140242
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DMTF1 MAP4 MAP4K3 ARHGAP26 MBNL1 HIPK2 DAG1 ANKRD50 ZBTB24 E2F8 PRDM2 UBAP2L VCAN LPP CEP295 DOT1L GEN1 PCDH18 BRWD1	4.41e-08	1084	135	19	11544199
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DENND4A UBAP2 MAP4 CEP85L ZCCHC8 BAG3 MLXIP E2F8 LUZP1 SVIL LPP XRN1 NUMB AKAP11 CLINT1 LIMCH1 GEN1	4.45e-08	861	135	17	36931259
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	UBAP2 MAP4 BAG3 DAG1 NUP214 LUZP1 SVIL LPP VSIG10L XRN1 NUMB CLINT1 LIMCH1 ACBD3	4.80e-08	565	135	14	25468996
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	UBAP2 MAP4 NUP214 LUZP1 UBAP2L XRN1 ASPM CLINT1 LIMCH1 KNL1	6.89e-08	256	135	10	33397691
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SMG1 SETD1A CAD UBAP2 NUP214 MED1 ITPR2 ITPR3 POM121 UBAP2L ASCC2 RPAP2	1.65e-07	440	135	12	34244565
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	MAP4 BAG3 SPART NUP214 LUZP1 ITPR3 UBAP2L ATP6AP2 XRN1 TACC1 CLINT1 LIMCH1 ACBD3	3.65e-07	568	135	13	37774976
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	UBAP2 MAP4 ZCCHC8 BAG3 SPART NUP214 MED1 PHGDH UBAP2L LPP XRN1 NUMB TACC1 CLINT1 ACBD3 KNL1	7.55e-07	934	135	16	33916271
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ATMIN SETD1A FRAS1 ARHGAP26 KAT6A KSR2 NUP214 MLLT10 MLXIP ITPR2 ITPR3 RPAP1 CELSR2 DISP2 WDFY3 DOT1L HR	1.45e-06	1105	135	17	35748872
Pubmed	E3 ubiquitin ligase FBXW7 balances airway cell fates.	PDPN KLF5 TP63 FBXW7	1.50e-06	22	135	4	34998785
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	SMG1 UBAP2 ARHGAP26 AGGF1 MUC16 MLXIP PRDM2 EPC1 TENM1 ZFHX2 AKAP11 MUC3A	1.79e-06	552	135	12	10737800
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	ZCCHC8 CCDC28A SNUPN MLXIP ANKRD50 PHGDH WDR45 RPAP1 UBAP2L KLF5 LPP XRN1 NUMB CLINT1 LIMCH1 RPAP2	2.95e-06	1038	135	16	26673895
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	POLA1 SPART NUP214 UBAP2L EPC1 XRN1 AKAP11 KNL1	5.07e-06	242	135	8	34011540
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	UBAP2 MAP4 POLA1 MBNL1 SPART MED1 LUZP1 UBAP2L XRN1 MARF1 ASCC2 CLINT1 GEN1	5.29e-06	724	135	13	36232890
Pubmed	Basement membrane distortions impair lung lobation and capillary organization in the mouse model for fraser syndrome.	FRAS1 PDPN NID1	6.73e-06	10	135	3	15623520
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	ZCCHC8 POLA1 MBNL1 BAG3 DAG1 SPART NUP214 LUZP1 POM121 LPP NUMB TACC1 CLINT1 ACBD3 RPAP2	9.21e-06	1007	135	15	34597346
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	POM121 SVIL LPP XRN1 TENM1 NUMB TACC1 ACBD3	9.31e-06	263	135	8	34702444
Pubmed	rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.	MBNL1 RBFOX1	1.50e-05	2	135	2	29789616
Pubmed	Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin.	ITPR2 ITPR3	1.50e-05	2	135	2	9065779
Pubmed	hDOT1L links histone methylation to leukemogenesis.	MLLT10 DOT1L	1.50e-05	2	135	2	15851025
Pubmed	Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	1.50e-05	2	135	2	8081734
Pubmed	Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias.	MLLT10 DOT1L	1.50e-05	2	135	2	19443658
Pubmed	The mammalian Golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosis.	NUMB ACBD3	1.50e-05	2	135	2	17418793
Pubmed	Molecular cloning of mouse type 2 and type 3 inositol 1,4,5-trisphosphate receptors and identification of a novel type 2 receptor splice variant.	ITPR2 ITPR3	1.50e-05	2	135	2	15632133
Pubmed	HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.	HIPK2 TP63	1.50e-05	2	135	2	21602882
Pubmed	UBAP2/UBAP2L regulate UV-induced ubiquitylation of RNA polymerase II and are the human orthologues of yeast Def1.	UBAP2 UBAP2L	1.50e-05	2	135	2	35633597
Pubmed	lingerer, a Drosophila gene involved in initiation and termination of copulation, encodes a set of novel cytoplasmic proteins.	UBAP2 UBAP2L	1.50e-05	2	135	2	12524348
Pubmed	Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.	CDH23 USH2A	1.50e-05	2	135	2	17360538
Pubmed	AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation.	MLLT10 DOT1L	1.50e-05	2	135	2	34215314
Pubmed	Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve.	ITPR2 ITPR3	1.50e-05	2	135	2	17496801
Pubmed	AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.	MLLT10 DOT1L	1.50e-05	2	135	2	25464900
Pubmed	Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye.	ITPR2 ITPR3	1.50e-05	2	135	2	24901844
Pubmed	Adrenergic inhibition facilitates normalization of extracellular potassium after cortical spreading depolarization.	ITPR2 ITPR3	1.50e-05	2	135	2	33854148
Pubmed	Pancreatic protease activation by alcohol metabolite depends on Ca2+ release via acid store IP3 receptors.	ITPR2 ITPR3	1.50e-05	2	135	2	19528657
Pubmed	Determination of relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction.	ITPR2 ITPR3	1.50e-05	2	135	2	8063813
Pubmed	C-Terminal region of teneurin-1 co-localizes with dystroglycan and modulates cytoskeletal organization through an extracellular signal-regulated kinase-dependent stathmin- and filamin A-mediated mechanism in hippocampal cells.	DAG1 TENM1	1.50e-05	2	135	2	22698694
Pubmed	A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.	CEP85L ITPR2	1.50e-05	2	135	2	22010048
Pubmed	IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism.	ITPR2 ITPR3	1.50e-05	2	135	2	16195467
Pubmed	FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.	MAP4 FBXW7	1.50e-05	2	135	2	36991467
Pubmed	RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1.	MBNL1 RBFOX1	1.50e-05	2	135	2	25211016
Pubmed	Inositol (1,4,5)-trisphosphate receptor links to filamentous actin are important for generating local Ca2+ signals in pancreatic acinar cells.	ITPR2 ITPR3	1.50e-05	2	135	2	15713744
Pubmed	DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.	PDPN TP63	1.50e-05	2	135	2	19773378
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	ATMIN CAD MAP4 KAT6A DOCK10 NUP214 PRDM10 HMCN2	1.58e-05	283	135	8	18854154
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	CAD POLA1 NUP214 SNUPN PHGDH PRDM2 RPAP1 UBAP2L	1.62e-05	284	135	8	29459677
Pubmed	Functional proteomics mapping of a human signaling pathway.	THAP5 DMTF1 SMG1 ZCCHC8 SPART SUSD1 ASCC2 NID1 ACBD3 SAP130 KNL1	2.08e-05	591	135	11	15231748
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	UBAP2 BAG3 SPART WDR45 XRN1 CLINT1 LIMCH1	2.28e-05	216	135	7	31519766
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	DENND4A ANKRD50 ITPR2 ITPR3 WDR45 ATP6AP2 TENM1 AKAP11 TACC1 ACBD3	2.93e-05	504	135	10	34432599
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZCCHC8 KAT6A MECOM LUZP1 HMCN2 EPC1 XRN1 ASPM CEP295 WDFY3 SAP130 KNL1 SOS1 BRWD1 RPAP2	3.04e-05	1116	135	15	31753913
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	CAD UBAP2 SPART MED1 UBAP2L RPAP2	3.21e-05	154	135	6	16055720
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ATMIN FRAS1 DOCK10 NUP214 MLXIP RPAP1 UBAP2L DISP2 LIMCH1	3.22e-05	407	135	9	12693553
Pubmed	Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening.	ZNF280B PDPN EPC1 TNFRSF19 FBXW7	3.23e-05	93	135	5	7829101
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	FRAS1 CAD MAP4 E2F8 ATP6AP2 SETBP1 XRN1 TENM1 NID1 TNFRSF19	3.40e-05	513	135	10	25798074
Pubmed	Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population.	CDH23 PMEL LPP	3.74e-05	17	135	3	22951725
Pubmed	CEBPA-Associated Familial Acute Myeloid Leukemia (AML)	NUP214 MLLT10 LPP	3.74e-05	17	135	3	20963938
Pubmed	ETV6 Thrombocytopenia and Predisposition to Leukemia	NUP214 MLLT10 LPP	3.74e-05	17	135	3	33226740
Pubmed	RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies	NUP214 MLLT10 LPP	3.74e-05	17	135	3	33661592
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	MAP4K3 CCDC28A DAG1 ANKRD50 ERICH5 HSPA12A CELSR2 NUMB ACBD3	4.18e-05	421	135	9	36976175
Pubmed	DDX41-Associated Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia	NUP214 MLLT10 LPP	4.47e-05	18	135	3	34723452
Pubmed	Evidence that type I, II, and III inositol 1,4,5-trisphosphate receptors can occur as integral plasma membrane proteins.	ITPR2 ITPR3	4.48e-05	3	135	2	10874040
Pubmed	Abnormal distribution of inositol 1,4,5-trisphosphate receptors in human muscle can be related to altered calcium signals and gene expression in Duchenne dystrophy-derived cells.	ITPR2 ITPR3	4.48e-05	3	135	2	20395455
Pubmed	Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.	PDPN TP63	4.48e-05	3	135	2	22257901
Pubmed	Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases.	ITPR2 ITPR3	4.48e-05	3	135	2	17437169
Pubmed	Klf5 acetylation regulates luminal differentiation of basal progenitors in prostate development and regeneration.	KLF5 TP63	4.48e-05	3	135	2	32081850
Pubmed	Decreased olfactory mucus secretion and nasal abnormality in mice lacking type 2 and type 3 IP3 receptors.	ITPR2 ITPR3	4.48e-05	3	135	2	18547250
Pubmed	Inositol 1,4,5-trisphosphate receptor gene variants are related to the risk of breast cancer in a Chinese population.	ITPR2 ITPR3	4.48e-05	3	135	2	36350267
Pubmed	The versatility and universality of calcium signalling.	ITPR2 ITPR3	4.48e-05	3	135	2	11413485
Pubmed	Using concatenated subunits to investigate the functional consequences of heterotetrameric inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	4.48e-05	3	135	2	26009177
Pubmed	Regulation of adipocyte differentiation by clusterin-mediated Krüppel-like factor 5 stabilization.	KLF5 FBXW7	4.48e-05	3	135	2	33078455
Pubmed	Receptor-activated single channels in intact human platelets.	ITPR2 ITPR3	4.48e-05	3	135	2	1693919
Pubmed	Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.	ITPR2 ITPR3	4.48e-05	3	135	2	23955339
Pubmed	Type 3 Inositol 1,4,5-Trisphosphate Receptor is a Crucial Regulator of Calcium Dynamics Mediated by Endoplasmic Reticulum in HEK Cells.	ITPR2 ITPR3	4.48e-05	3	135	2	31979185
Pubmed	Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly.	ITPR2 ITPR3	4.48e-05	3	135	2	24904548
Pubmed	Deletion of the prorenin receptor in the ureteric bud in mice inhibits Dot1/H3K79 pathway.	ATP6AP2 DOT1L	4.48e-05	3	135	2	38287105
Pubmed	TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.	KLF5 TP63	4.48e-05	3	135	2	32619460
Pubmed	Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer.	KLF5 TP63	4.48e-05	3	135	2	34272396
Pubmed	POMT1 is essential for protein O-mannosylation in mammals.	DAG1 NID1	4.48e-05	3	135	2	20816174
Pubmed	Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes.	ITPR2 ITPR3	4.48e-05	3	135	2	9858485
Pubmed	A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).	KLF5 FBXW7	4.48e-05	3	135	2	24398687
Pubmed	Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland.	ITPR2 ITPR3	4.48e-05	3	135	2	21435446
Pubmed	Expression of inositol 1,4,5-trisphosphate receptors in mouse oocytes and early embryos: the type I isoform is upregulated in oocytes and downregulated after fertilization.	ITPR2 ITPR3	4.48e-05	3	135	2	9808793
Pubmed	ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.	ASPM FBXW7	4.48e-05	3	135	2	38279565
Pubmed	The DOT1L-MLLT10 complex regulates male fertility and promotes histone removal during spermiogenesis.	MLLT10 DOT1L	4.48e-05	3	135	2	37082953
Pubmed	Type 2 and type 3 inositol 1,4,5-trisphosphate (IP3) receptors promote the differentiation of granule cell precursors in the postnatal cerebellum.	ITPR2 ITPR3	4.48e-05	3	135	2	18194433
Pubmed	Persistent stromal fibroblast activation is present in chronic tendinopathy.	PDPN VCAM1	4.48e-05	3	135	2	28122639
Pubmed	D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.	PDPN TP63	4.48e-05	3	135	2	21326813
Pubmed	IP3 receptors regulate vascular smooth muscle contractility and hypertension.	ITPR2 ITPR3	4.48e-05	3	135	2	27777977
Pubmed	The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.	KLF5 FBXW7	4.48e-05	3	135	2	20388706
Pubmed	Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line.	ITPR2 ITPR3	4.48e-05	3	135	2	17581770
Pubmed	Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction.	ITPR2 ITPR3	4.48e-05	3	135	2	18241669
Pubmed	Granulosa cells express three inositol 1,4,5-trisphosphate receptor isoforms: cytoplasmic and nuclear Ca2+ mobilization.	ITPR2 ITPR3	4.48e-05	3	135	2	19068129
Pubmed	Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	4.48e-05	3	135	2	17327232
Pubmed	Nuclear inositol 1,4,5-trisphosphate receptors regulate local Ca2+ transients and modulate cAMP response element binding protein phosphorylation.	ITPR2 ITPR3	4.48e-05	3	135	2	16014380
Pubmed	Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.	MECOM SETBP1	4.48e-05	3	135	2	16582916
Pubmed	Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice.	ITPR2 ITPR3	4.48e-05	3	135	2	17890015
Pubmed	Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.	ITPR2 ITPR3	4.48e-05	3	135	2	23983250
Pubmed	MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation.	TP63 FBXW7	4.48e-05	3	135	2	20571051
Pubmed	Family with sequence similarity 5, member C (FAM5C) increases leukocyte adhesion molecules in vascular endothelial cells: implication in vascular inflammation.	BRINP3 VCAM1	4.48e-05	3	135	2	25251368
Interaction	G3BP1 interactions	CAD ARHGAP24 UBAP2 MAP4 MAP4K3 BAG3 NUP214 ITGA2B LUZP1 UBAP2L KLF5 LPP RBFOX1 DOT1L ACBD3 SAP130 VCAM1 FBXW7 RPAP2	2.18e-06	835	132	19	int:G3BP1
Interaction	MYH9 interactions	DENND4A CAD ARHGAP24 GRIA4 LUZP1 ITPR2 ITPR3 PTP4A3 TP63 SVIL ASCC2 CLINT1 LIMCH1 DOT1L ACBD3 VCAM1 FBXW7	8.87e-06	754	132	17	int:MYH9
Interaction	VIM interactions	CAD ARHGAP24 MBNL1 BAG3 DOCK10 SPART GRIA4 ITGA2B PHGDH LUZP1 ATP6AP2 NFIX SVIL LPP NUMB VCAM1 RPAP2	2.03e-05	804	132	17	int:VIM
Interaction	TJP2 interactions	MBNL1 ANKRD50 LUZP1 PTP4A3 SVIL LPP LIMCH1 ACBD3 FBXW7 RPAP2	2.05e-05	288	132	10	int:TJP2
Interaction	TOP3B interactions	ATMIN SETD1A FRAS1 CAD UBAP2 ARHGAP26 KAT6A KSR2 NUP214 MLLT10 MLXIP PHGDH ITPR2 ITPR3 RPAP1 CELSR2 UBAP2L ATP6AP2 SVIL XRN1 DISP2 WDFY3 DOT1L HR	2.73e-05	1470	132	24	int:TOP3B
Interaction	VCL interactions	ARHGAP24 DAG1 NFIX TP63 SVIL LPP ASCC2 VCAM1 KNL1 RPAP2	3.34e-05	305	132	10	int:VCL
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD1A MECOM PRDM2 DOT1L	1.64e-05	34	82	4	487
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	MECOM PRDM2 PRDM10	5.84e-05	17	82	3	1197
GeneFamily	Inositol 1,4,5-triphosphate receptors\|Protein phosphatase 1 regulatory subunits	ITPR2 ITPR3	6.08e-05	3	82	2	297
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ITGA2B ITPR3 MARF1 AKAP11 KNL1	1.39e-03	181	82	5	694
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP24 ARHGAP26 ARHGAP20	1.51e-03	50	82	3	721
Coexpression	SHEN_SMARCA2_TARGETS_UP	ATMIN GIN1 MAP4K3 MFSD6 AGGF1 ATP6AP2 MARF1 NUMB AKAP11 CLINT1 LIMCH1 WDFY3	2.21e-06	429	134	12	M29
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	FRAS1 ARHGAP24 MAP4K3 MECOM PIK3C2G SVIL TACC1 LIMCH1	1.22e-05	208	134	8	M39233
Coexpression	LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX	KANSL1L MAP4K3 MBNL1 HIPK2 ITPR2 SETBP1 LIMCH1	1.36e-05	152	134	7	M39239
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	DMTF1 SMG1 DENND4A CEP85L STK17B KAT6A MBNL1 DOCK10 AGGF1 MED1 LUZP1 PRDM2 ITPR2 ATP6AP2 EPC1 XRN1 AKAP11 TACC1 TMEM123 SOS1 BRWD1	2.28e-05	1492	134	21	M40023
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	KANSL1L FRAS1 MAP4K3 MECOM PIK3C2G SETBP1 LIMCH1	2.91e-05	171	134	7	M39234
Coexpression	LIM_MAMMARY_STEM_CELL_UP	ARHGAP24 MBNL1 BAG3 DOCK10 LUZP1 PDPN TP63 VCAN TACC1 ARHGAP20 PCDH18	3.70e-05	479	134	11	M2573
Coexpression	LIM_MAMMARY_STEM_CELL_UP	ARHGAP24 MBNL1 BAG3 DOCK10 LUZP1 PDPN TP63 VCAN TACC1 ARHGAP20 PCDH18	3.99e-05	483	134	11	MM1082
Coexpression	LIAO_HAVE_SOX4_BINDING_SITES	UBAP2 MAP4 UBAP2L VCAN	5.71e-05	41	134	4	M15025
Coexpression	GSE25087_TREG_VS_TCONV_ADULT_DN	CAD BAG3 HIPK2 ZNF280B ZBTB26 ANKRD50 SVIL	6.70e-05	195	134	7	M4652
Coexpression	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	POLA1 CCDC150 MECOM E2F8 GEN1 KNL1 BRWD1	6.70e-05	195	134	7	M13736
Coexpression	GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	SETD1A HIPK2 MLXIP RGS18 SUSD1 UBAP2L	6.70e-05	134	134	6	M430
Coexpression	GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN	UBAP2 AGGF1 PRDM10 SAP130 PARM1 KNL1 SOS1	7.38e-05	198	134	7	M7267
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	ARHGAP26 MBNL1 HIPK2 SVIL TACC1 LIMCH1	7.58e-05	137	134	6	M39241
Coexpression	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN	DAG1 ITPR2 RPAP1 CELSR2 KLF5 TP63 SVIL	7.61e-05	199	134	7	M7319
Coexpression	GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP	MAP4 MAP4K3 ITPR2 IGHM EPC1 XRN1 ASPM	7.86e-05	200	134	7	M3428
Coexpression	CUI_TCF21_TARGETS_2_UP	FRAS1 CAD PHGDH NFIX KLF5 VCAN ASPM VCAM1 PARM1 KNL1	8.69e-05	437	134	10	M1610
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	CAD MAP4 DAG1 ITPR3 HSPA12A CELSR2 UBAP2L VCAN	9.06e-05	276	134	8	M3063
Coexpression	CUI_TCF21_TARGETS_2_UP	FRAS1 CAD PHGDH NFIX KLF5 VCAN ASPM VCAM1 PARM1 KNL1	1.21e-04	455	134	10	MM1189
Coexpression	MARTINEZ_RESPONSE_TO_TRABECTEDIN	POLA1 LPP MARF1 NUMB	1.25e-04	50	134	4	M5077
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	ARHGAP24 POLA1 FKBP9 MUC16 GRIA4 ANKRD50 E2F8 PDPN HSPA12A NFIX VCAN SVIL ASPM NID1 ARHGAP20 GEN1 PCDH18 VCAM1	1.45e-06	773	132	18	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FRAS1 ARHGAP24 SPART MUC16 GRIA4 E2F8 HSPA12A NFIX VCAN SVIL LPP NID1 ARHGAP20 GEN1 PCDH18 VCAM1 PARM1 KNL1	1.56e-06	777	132	18	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000	FRAS1 ARHGAP24 HIPK2 MECOM E2F8 HSPA12A CELSR2 SUSD1 NFIX VCAN RBFOX1 ASPM CLINT1 GEN1 VCAM1 KNL1	2.93e-05	783	132	16	gudmap_kidney_P4_CapMesRenVes_Crym_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FKBP9 DOCK10 SPART MUC16 GRIA4 E2F8 HSPA12A VCAN SVIL ASPM NID1 ARHGAP20 GEN1 PCDH18 VCAM1 KNL1	3.41e-05	793	132	16	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	SMG1 SETD1A MAP4 LPP ASPM CEP295 WDFY3 ARHGAP20 KNL1	3.58e-05	259	132	9	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3	POLA1 FKBP9 MECOM E2F8 RGS18 SUSD1 SETBP1 ASPM WDFY3 GEN1 KNL1	6.88e-05	423	132	11	GSM791126_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	POLA1 FKBP9 DOCK10 MUC16 GRIA4 ANKRD50 PDPN HSPA12A VCAN SVIL ASPM NID1 ARHGAP20 PCDH18 VCAM1	8.77e-05	768	132	15	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000	CEP85L MAP4K3 ARHGAP26 DOCK10 MECOM ANKRD50 LUZP1 HSPA12A NFIX SETBP1 LPP NID1 CD302 TACC1 PCDH18 VCAM1	1.04e-04	872	132	16	gudmap_kidney_adult_Mesangium_Meis_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	GIN1 POLA1 MECOM LUZP1 CELSR2 PTPRZ1 KLF5 SETBP1 ASPM ZFHX2 TNFRSF19 CEP295 TMEM123 GEN1 KNL1 FBXW7 BRWD1	1.38e-04	989	132	17	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	GIN1 POLA1 MECOM LUZP1 SETBP1 ASPM CEP295 GEN1 KNL1	1.45e-04	311	132	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500	SETD1A MAP4 LPP CEP295 WDFY3 ARHGAP20	2.09e-04	136	132	6	gudmap_developingGonad_P2_epididymis_500_k2
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	DENND4A BAG3 FKBP9 MUC16 ITPR2 NFIX VCAN RBFOX1 NUMB MANSC4 AKAP11 TNFRSF19 ARHGAP20 PCDH18	2.12e-04	740	132	14	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	Stem Cells, SC.ST34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34+, Bone marrow, avg-2	POLA1 FKBP9 MECOM ITGA2B RGS18 SUSD1 NFIX ASPM WDFY3 KNL1	2.54e-04	411	132	10	GSM791112_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	POLA1 MFSD6 MECOM LUZP1 PDPN CELSR2 PTPRZ1 SETBP1 ASPM TMEM123 FBXW7	2.62e-04	493	132	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4	KAT6A UBAP2L NUMB WDFY3 ACBD3 SOS1 BRWD1	2.83e-04	203	132	7	Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2	POLA1 FKBP9 MECOM ITGA2B E2F8 RGS18 SUSD1 NFIX WDFY3 KNL1	3.13e-04	422	132	10	GSM399442_500
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	SETD1A GIN1 DAG1 FETUB ITPR2 UBAP2L NFIX TP63 LPP MARF1 NID1 TNFRSF19 CEP295 WDFY3	3.17e-04	770	132	14	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000	DOCK10 MECOM ANKRD50 SETBP1 LPP NID1 TACC1 PCDH18 VCAM1	3.33e-04	348	132	9	gudmap_kidney_adult_Mesangium_Meis_k2_1000
CoexpressionAtlas	B cells, B.T2.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3	DENND4A ARHGAP24 ARHGAP26 ITPR3 PTP4A3 RGS18 SUSD1 TMEM123 BRWD1	3.33e-04	348	132	9	GSM538216_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	DMTF1 SMG1 KAT6A PRDM2 CELSR2 PTPRZ1 NUMB CEP295 WDFY3 ACBD3 SAP130 SOS1	3.45e-04	595	132	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_1000	FRAS1 DENND4A STK17B MBNL1 DOCK10 MUC16 GRIA4 PDPN PTPRZ1 NFIX KLF5 SVIL NID1 CD302	3.52e-04	778	132	14	gudmap_kidney_adult_RenalCapsule_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	SETD1A MAP4 LPP ASPM CEP295 WDFY3	3.54e-04	150	132	6	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4	BAG3 FKBP9 PDPN NFIX VCAN NID1 CD302 ARHGAP20 PCDH18 VCAM1	4.12e-04	437	132	10	GSM777046_500
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	SMG1 MED1 LUZP1 PRDM10 LPP MARF1 CEP295 SAP130 SOS1	6.19e-09	186	136	9	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MAP4K3 ARHGAP26 MECOM ITPR2 LPP LIMCH1 WDFY3 FBXW7 SOS1	1.11e-08	199	136	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SPATA3 BRINP3 KSR2 MECOM GRIA4 SUSD1 PIK3C2G LIMCH1	1.77e-08	147	136	8	b66ccc710b3c04f6fc7fed69f3c892fc110e98fc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 MAP4 KSR2 DOCK10 MECOM SUSD1 PIK3C2G LIMCH1	8.54e-08	180	136	8	023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SMG1 DENND4A CEP85L ARHGAP26 MBNL1 DOCK10 PRDM2 LPP	1.19e-07	188	136	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 BRINP3 KSR2 MECOM CNTNAP5 SUSD1 PIK3C2G LIMCH1	1.19e-07	188	136	8	58ccb31cdf43167872ef0fc737e6f9c51ee2e060
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 MAP4K3 MECOM SUSD1 PIK3C2G SETBP1 TNFRSF19 LIMCH1	1.29e-07	190	136	8	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP24 PDPN NFIX VCAN XRN1 NID1 CD302 ARHGAP20	1.35e-07	191	136	8	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A ARHGAP24 PRDM2 IGHM SETBP1 GEN1 KNL1 PARP15	1.58e-07	195	136	8	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A ARHGAP24 PRDM2 IGHM SETBP1 GEN1 KNL1 PARP15	1.58e-07	195	136	8	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BAG3 FKBP9 PDPN NFIX VCAN NID1 CD302 VCAM1	1.58e-07	195	136	8	773728703bc8969bff0e1de58fe3e1631add0a0a
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	KANSL1L ARHGAP24 MAP4K3 MECOM LPP LIMCH1 FBXW7 SOS1	1.64e-07	196	136	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	STK17B MBNL1 PRDM2 EPC1 XRN1 TACC1 CLINT1 TMEM123	1.92e-07	200	136	8	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BRINP3 BAG3 DOCK10 PTPRZ1 SVIL LIMCH1 PCDH18	3.87e-07	149	136	7	10ffd0051fb027bbebc662ca602c80d89bbf99c6
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DENND4A ARHGAP24 STK17B KAT6A MBNL1 PRDM2 IGHM	9.05e-07	169	136	7	c3a6179a64589a370108fea809b157839347759c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 MAP4K3 KSR2 MECOM PIK3C2G TNFRSF19 LIMCH1	1.33e-06	179	136	7	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 ARHGAP26 KAT6A DOCK10 CLEC7A XRN1 CLINT1	1.48e-06	182	136	7	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 MAP4K3 KSR2 MECOM SUSD1 PIK3C2G LIMCH1	1.48e-06	182	136	7	f96095b81188b52db8fcfca4837129cfcd9bd7b7
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte-2\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ITGA2B PHGDH PDPN HSPA12A KLF5 PARM1	1.60e-06	184	136	7	e123ad8ee46a032825a0bd4b3586ddcb3eda03d4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L FRAS1 KSR2 MECOM SUSD1 PIK3C2G LIMCH1	1.66e-06	185	136	7	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 MAP4K3 MECOM SUSD1 PIK3C2G SETBP1 LIMCH1	1.72e-06	186	136	7	08632045d499e61dd96ff29a5a9a208afe58dc58
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 CEP85L KAT6A HIPK2 LUZP1 PTP4A3 NUMB	1.78e-06	187	136	7	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4 PHGDH ITPR2 KLF5 TP63 TNFRSF19 LIMCH1	1.78e-06	187	136	7	9c1013720c248ef201d010806b6e7ad24205e8ee
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 DAG1 PHGDH PDPN HSPA12A KLF5 PARM1	1.78e-06	187	136	7	806075c2531a7f5c1da38b85ea494a3b4b5e92ec
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 BRINP3 KSR2 MECOM SUSD1 PIK3C2G LIMCH1	1.78e-06	187	136	7	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 MAP4K3 MECOM SUSD1 PIK3C2G SETBP1 LIMCH1	1.91e-06	189	136	7	8ff3c3232eff9de4b5c9b22ecb82bc509d773f58
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 MAP4K3 MECOM SUSD1 PIK3C2G TNFRSF19 LIMCH1	1.91e-06	189	136	7	90aae7e806882bebfad78a78e9a16cf56af3ecd4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 BRINP3 KSR2 MECOM SUSD1 PIK3C2G LIMCH1	1.91e-06	189	136	7	c9565e962a13a7713056ec3dbb1b67d24f9889c7
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	ARHGAP26 HIPK2 MECOM ITPR2 VCAN SETBP1 TACC1	1.91e-06	189	136	7	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	ARHGAP26 HIPK2 MECOM ITPR2 SETBP1 NUMB TACC1	1.91e-06	189	136	7	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 DAG1 PDPN FHAD1 KLF5 VCAM1 PARM1	1.91e-06	189	136	7	319e42f6e2322208de78bc666fb2c074707eb4da
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TRABD2A TRAV6 STK17B DOCK10 CD226 TENM1 TMEM123	1.98e-06	190	136	7	2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMTF1 STK17B MBNL1 DOCK10 CD226 XRN1 PARP15	1.98e-06	190	136	7	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP4K3 KSR2 MECOM CNTNAP5 SUSD1 PIK3C2G LIMCH1	1.98e-06	190	136	7	b3bccf4dd95e986db3cee324a6737f5fcc22e8e5
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 DAG1 PDPN FHAD1 KLF5 VCAM1 PARM1	1.98e-06	190	136	7	050d6e0546954675b6adbfecb67854b1e09739d1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2A CEP85L STK17B MBNL1 DOCK10 CD226 PARP15	1.98e-06	190	136	7	07ea0578ca0561077557203ae660530f53fc4067
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2A CEP85L STK17B MBNL1 DOCK10 CD226 PARP15	1.98e-06	190	136	7	5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2A CEP85L STK17B MBNL1 DOCK10 CD226 PARP15	2.05e-06	191	136	7	d9506b88d806aadd4c2b9bf86fe994c47799e7f6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2A CEP85L STK17B MBNL1 DOCK10 CD226 PARP15	2.05e-06	191	136	7	b42c54308abe1241cc38ddce96b9d38d07983891
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 MECOM ITPR3 KLF5 SVIL RBFOX1 CLINT1	2.05e-06	191	136	7	5a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 MECOM ITPR3 KLF5 SVIL RBFOX1 CLINT1	2.05e-06	191	136	7	55ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 BAG3 NFIX KLF5 VCAM1 PARM1 HR	2.05e-06	191	136	7	8691eba35793e4e90f93d50c2145847ee51289f7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2A CEP85L STK17B MBNL1 DOCK10 CD226 PARP15	2.05e-06	191	136	7	9aabbc65430e2233b8f2d3fff9face7807b88b48
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	DENND4A ARHGAP24 PRDM2 SETBP1 AKAP11 GEN1 PARP15	2.19e-06	193	136	7	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	FRAS1 MBNL1 ITPR2 VCAN TNFRSF19 TACC1 SOS1	2.19e-06	193	136	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A ARHGAP24 PRDM2 IGHM SETBP1 GEN1 PARP15	2.27e-06	194	136	7	5cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 BRINP3 KSR2 MECOM CELSR2 PIK3C2G KLF5	2.27e-06	194	136	7	be869e186386d03ebb670971dd24fa656b4b0edf
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CLEC7A RGS18 CELSR2 CD226 VCAM1 PARM1 HR	2.27e-06	194	136	7	5a048bd2af30975fdc57ff40bc49aa5811c830d8
ToppCell	11.5-Distal-Epithelial-Bud_tip_progenitor\|Distal / Age, Tissue, Lineage and Cell class	TRABD2A ERICH5 E2F8 ITPR3 PIK3C2G PTPRZ1 PARM1	2.43e-06	196	136	7	42eae265e2f2082983d8c2607c7f6a53a526d124
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A MAP4 MBNL1 FKBP9 DAG1 LPP TMEM123	2.43e-06	196	136	7	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ARHGAP24 DOCK10 RBFOX1 NID1 TACC1 PCDH18 VCAM1	2.60e-06	198	136	7	72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	KANSL1L ARHGAP24 MAP4K3 MECOM LPP LIMCH1 WDFY3	2.60e-06	198	136	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	facs-Trachea-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BAG3 FKBP9 PDPN NFIX VCAN NID1 CD302	2.60e-06	198	136	7	e85ae846e293687fd193f4d565525d8d3bd1faea
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	STK17B CLEC7A NUP214 CACNA2D4 RGS18 VCAN CD302	2.60e-06	198	136	7	6d547122b8c4ddbdd0d3dae3bce4a125740d5457
ToppCell	distal-1-mesenchymal-Mesothelial\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FRAS1 MUC16 GRIA4 PHGDH PDPN RBFOX1 VCAM1	2.69e-06	199	136	7	8dd5b411d2f1626830b77a1616cc3fb67dc59338
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDPN VCAN NID1 CD302 LIMCH1 ARHGAP20 VCAM1	2.69e-06	199	136	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	VCAN NID1 CD302 LIMCH1 ARHGAP20 PCDH18 VCAM1	2.69e-06	199	136	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related-Oligodendrocyte/OPC\|2m / Sample Type, Dataset, Time_group, and Cell type.	PTPRZ1 NFIX SETBP1 TMEM123 PCDH18 VCAM1 FBXW7	2.78e-06	200	136	7	3c9a2f02294a9fb892b89e856291bd6423ffa0a9
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related\|2m / Sample Type, Dataset, Time_group, and Cell type.	PTPRZ1 NFIX SETBP1 TMEM123 PCDH18 VCAM1 FBXW7	2.78e-06	200	136	7	8e49e7e9b02d8411e4ffae1f5113a2c18f5bf179
ToppCell	Sigmoid-(4)_Monocyte\|Sigmoid / shred on region, Cell_type, and subtype	CLEC7A RGS18 SUSD1 VCAN NID1 CD302 WDFY3	2.78e-06	200	136	7	7f3920a0434d5199c6c8f0b3064a305bb0d87b60
ToppCell	Sigmoid-Monocyte-Monocyte\|Sigmoid / Region, Cell class and subclass	CLEC7A RGS18 SUSD1 VCAN NID1 CD302 WDFY3	2.78e-06	200	136	7	010ca36970cb8894bdbca08779c0ecf56be22fc9
ToppCell	Sigmoid-Monocyte\|Sigmoid / Region, Cell class and subclass	CLEC7A RGS18 SUSD1 VCAN NID1 CD302 WDFY3	2.78e-06	200	136	7	c41bd6ec0f2262fce5cadb37a400d487e6662f49
ToppCell	Sigmoid-(4)_Monocyte-(40)_Monocyte\|Sigmoid / shred on region, Cell_type, and subtype	CLEC7A RGS18 SUSD1 VCAN NID1 CD302 WDFY3	2.78e-06	200	136	7	576c0a1098e6a934448705de3673ef798fcf1b26
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Macroglial-Glia_progenitor_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	CEP85L SPART PHGDH PDPN PTPRZ1 LIMCH1 TMEM123	2.78e-06	200	136	7	4859fbe663ae9372fc8ed3b4e1fa301e06621a31
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PMEL E2F8 ITPR2 PDPN PTPRZ1 VCAN	3.42e-06	133	136	6	63d2f096ae47d9b587acc6c5fbd346e5e58842b8
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BRINP3 ARHGAP24 DOCK10 PTPRZ1 LIMCH1 PCDH18	5.40e-06	144	136	6	7de962346ba9653d90dd13bb7d977fe44d200bba
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARHGAP24 DOCK10 PTPRZ1 VCAN PCDH18 PARM1	7.37e-06	152	136	6	8ff5a178a8f3550d89a003c0858820aab3773386
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BAG3 DOCK10 PTPRZ1 SVIL LIMCH1 PCDH18	8.24e-06	155	136	6	cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658
ToppCell	COVID-19_Moderate-multiplets\|World / disease group, cell group and cell class	ERICH5 ITPR3 CD226 IGHM ARHGAP20 PARP15	8.55e-06	156	136	6	afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPATA3 FRAS1 GRIA4 PIK3C2G PTPRZ1 USH2A	9.88e-06	160	136	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPATA3 FRAS1 GRIA4 PIK3C2G PTPRZ1 USH2A	9.88e-06	160	136	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	mild_COVID-19_(asymptomatic)-B_intermediate\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	ARHGAP24 PRDM2 IGHM SETBP1 GEN1 KNL1	1.22e-05	166	136	6	8de8f388f24436b84e19ef460476fdbda4d16abf
ToppCell	droplet-Thymus-nan-3m-Myeloid-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAG1 ITGA2B HSPA12A NID1 TMEM123 VCAM1	1.22e-05	166	136	6	c0af93db981dfd448abc7efcd257f3e5ff066aae
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP4K3 MECOM SUSD1 PIK3C2G LIMCH1 DOT1L	1.26e-05	167	136	6	edc5f04584b44f99ff9a62bbe0dab6fc044fb334
ToppCell	Control-B_cells-Activated_B_cells\|Control / group, cell type (main and fine annotations)	ARHGAP24 DOCK10 PRDM2 IGHM SETBP1 PARP15	1.30e-05	168	136	6	a7159a35fe37f8c241cf8d391debe271e0698105
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	E2F8 VCAN ASPM LIMCH1 GEN1 KNL1	1.35e-05	169	136	6	563c267edaade0e5df192ad953801ef9768d4270
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BRINP3 ARHGAP24 PTPRZ1 SVIL LIMCH1 PCDH18	1.44e-05	171	136	6	5efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCell	3'_v3-Lung-Lymphocytic_B-Memory_B_cells\|Lung / Manually curated celltypes from each tissue	ARHGAP24 PRDM2 HSPA12A IGHM SETBP1 PARM1	1.44e-05	171	136	6	9ecef653f6916572bf5fbee5aea6c577d04e96ba
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARHGAP24 PRDM2 IGHM SETBP1 GEN1 PARP15	1.44e-05	171	136	6	a2938e56cb5749004317798dc7ac0f0c2d4d8ae0
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARHGAP24 DOCK10 PTPRZ1 SVIL LIMCH1 PCDH18	1.49e-05	172	136	6	7e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAD STK17B E2F8 RGS18 SUSD1 KLF5	1.54e-05	173	136	6	53e97835d7a518c278e7b90a0734eb0095d6aa33
ToppCell	droplet-Lung-LUNG-1m-Myeloid-basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAD STK17B E2F8 RGS18 SUSD1 KLF5	1.54e-05	173	136	6	889a880de5fc19d26b82cfef3067869a28ef17ca
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARHGAP24 PRDM2 SETBP1 GEN1 KNL1 PARP15	1.59e-05	174	136	6	ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e
ToppCell	severe_influenza-Plasmablast\|World / disease group, cell group and cell class (v2)	PHGDH E2F8 TP63 ASPM MANSC4 PARM1	1.64e-05	175	136	6	e6d6c44510d5dc4eb0bae820125e42366f7a4e74
ToppCell	P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FRAS1 DAG1 PDPN WDR45 KLF5 LIMCH1	1.70e-05	176	136	6	f3a54038cde58326f1caed96ecca33c141bcc8b3
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BRINP3 PDPN CNTNAP5 PTPRZ1 LPP PARM1	1.75e-05	177	136	6	f902600c639087664316b3cf30cab243bc3d1c5c
ToppCell	COVID-19-lung-B_cells\|lung / Disease (COVID-19 only), tissue and cell type	ARHGAP24 STK17B PRDM2 IGHM SETBP1 PARP15	1.75e-05	177	136	6	f54691e5558091c1734ab15153a10bff15ed171e
ToppCell	COVID-19-B_cells-Activated_B_cells\|COVID-19 / group, cell type (main and fine annotations)	ARHGAP24 STK17B PRDM2 IGHM SETBP1 PARP15	1.75e-05	177	136	6	653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THAP5 MFSD6 KSR2 SETBP1 RBFOX1 DOT1L	1.75e-05	177	136	6	e1e45956887371b1c18f1eb479dd930031497520
ToppCell	3'_v3-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	ARHGAP24 PRDM2 HSPA12A IGHM SETBP1 PARM1	1.93e-05	180	136	6	237a2130a3f48595dad2417539c21e44585962b8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 KSR2 MECOM SUSD1 PIK3C2G LIMCH1	1.93e-05	180	136	6	788d5fbf688365b5d92d3aa19b9f8e9448f8be5a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 BRINP3 KSR2 MECOM SUSD1 PIK3C2G	1.99e-05	181	136	6	b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1\|bone_marrow / Manually curated celltypes from each tissue	CCDC150 PHGDH VCAN ASPM CD302 KNL1	1.99e-05	181	136	6	ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPA12A CELSR2 ASPM TENM1 CEP295 SAP130	2.05e-05	182	136	6	39f9b3eb22293cc27c6e175702c77d1eeb24fdc9
ToppCell	P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARHGAP24 FKBP9 CD302 TACC1 LIMCH1 VCAM1	2.05e-05	182	136	6	19c5e3a9d9b3728303b682102e276adfe93aa759
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARHGAP24 IGHM SETBP1 GEN1 PARM1 PARP15	2.05e-05	182	136	6	9c120ddd109103ef6fac9c32b84d16a7624d0580
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	POLA1 DAG1 PMEL PIK3C2G WDFY3 DOT1L	2.12e-05	183	136	6	91079a11685dd466bd27a0cf5afbf3734c08a05e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 BRINP3 KSR2 MECOM PIK3C2G LIMCH1	2.12e-05	183	136	6	b5ede5a0048c585b73c00e88aeddbcaf669347b1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 MAP4K3 MECOM PIK3C2G TNFRSF19 LIMCH1	2.12e-05	183	136	6	2e831a4d99c6f983793df71c0994124c943c6da9
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARHGAP24 PRDM2 IGHM SETBP1 PARP15 FBXW7	2.18e-05	184	136	6	911658e7bb499c1bbc8419eec8ff88729bc39a75
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A	ARHGAP24 MFSD6 DAG1 ZNF280B NUP214 MLLT10 VCAN RBFOX1 TENM1 PARM1	2.18e-07	197	131	10	6335_UP
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	MAP4 STK17B ARHGAP26 KAT6A MLLT10 VCAN ZFHX2 WDFY3 BRWD1	2.16e-06	197	131	9	5746_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZCCHC8 HIPK2 SNUPN MLLT10 E2F8 PRDM10 WDFY3 BRWD1	9.10e-06	178	131	8	5086_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	MAP4 KAT6A MFSD6 MBNL1 PRDM2 ITPR2 CLINT1 WDFY3	1.41e-05	189	131	8	3788_DN
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A	MAP4 DOCK10 HIPK2 CLEC7A LUZP1 VCAN SVIL FBXW7	1.77e-05	195	131	8	2336_DN
Drug	Loracarbef [121961-22-6]; Down 200; 10.8uM; PC3; HT_HG-U133A	ARHGAP24 KAT6A MFSD6 HIPK2 MLLT10 KLF5 VCAN LPP	1.83e-05	196	131	8	5073_DN
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A	MAP4 ARHGAP26 MBNL1 MLLT10 VCAN SVIL NUMB SOS1	1.90e-05	197	131	8	2082_DN
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; MCF7; HT_HG-U133A	SPART NUP214 ITPR3 RPAP1 CD302 LIMCH1 FBXW7 SOS1	1.97e-05	198	131	8	4992_DN
Drug	SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A	DMTF1 MAP4K3 E2F8 UBAP2L KLF5 CD302 LIMCH1 WDFY3	1.97e-05	198	131	8	6909_UP
Drug	PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A	KAT6A DOCK10 ITPR2 RPAP1 KLF5 LPP WDFY3 FBXW7	1.97e-05	198	131	8	6550_UP
Drug	Erythromycin [114-07-8]; Up 200; 5.4uM; PC3; HG-U133A	AGGF1 DAG1 SPART MLLT10 LPP NID1 LIMCH1 PARM1	1.97e-05	198	131	8	1928_UP
Drug	Arecoline hydrobromide [300-08-3]; Up 200; 17uM; MCF7; HT_HG-U133A	KANSL1L DOCK10 PMEL ITPR2 ITPR3 TP63 NID1 WDFY3	2.04e-05	199	131	8	5423_UP
Drug	adenophostin A	ITPR2 ITPR3	3.29e-05	2	131	2	ctd:C085029
Drug	Strophanthidin [66-28-4]; Up 200; 9.8uM; HL60; HT_HG-U133A	STK17B ARHGAP26 KAT6A SPART PRDM10 LPP FBXW7	5.05e-05	166	131	7	2525_UP
Drug	Thimerosal	KANSL1L MAP4 GIN1 KAT6A BAG3 HIPK2 MECOM LYSMD4 LUZP1 PRDM2 ITPR3 PTP4A3 EPC1 VSIG10L ASPM AKAP11 WDFY3 KNL1 BRWD1	5.69e-05	1199	131	19	ctd:D013849
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A	KANSL1L UBAP2 STK17B ARHGAP26 KAT6A MED1 FBXW7	6.80e-05	174	131	7	1302_UP
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	BRINP3 STK17B MLLT10 MED1 E2F8 PRDM10 ASPM	7.57e-05	177	131	7	841_DN
Drug	retinoic acid; Down 200; 1uM; HL60; HT_HG-U133A	MAP4 STK17B ARHGAP26 CLEC7A KLF5 VCAN NUMB	1.07e-04	187	131	7	2671_DN
Drug	Alsterpaullone; Down 200; 10uM; MCF7; HT_HG-U133A	BRINP3 GIN1 ZBTB24 E2F8 PRDM2 ASPM SAP130	1.07e-04	187	131	7	7051_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	MAP4 KAT6A MFSD6 AGGF1 MED1 VCAN PARM1	1.22e-04	191	131	7	6644_DN
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	KAT6A NUMB CD302 TACC1 CLINT1 SOS1 RPAP2	1.30e-04	193	131	7	4846_DN
Drug	Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	KAT6A AGGF1 SPART MECOM PTP4A3 TACC1 FBXW7	1.34e-04	194	131	7	5544_DN
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	DOCK10 HIPK2 AGGF1 MLLT10 AKAP11 WDFY3 BRWD1	1.34e-04	194	131	7	4662_DN
Drug	F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A	BRINP3 PMEL PRDM2 ITPR2 PTP4A3 KLF5 LIMCH1	1.38e-04	195	131	7	6424_DN
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; HL60; HG-U133A	DENND4A MAP4 ZCCHC8 SPART MED1 LUZP1 PTP4A3	1.38e-04	195	131	7	2006_DN
Drug	Niclosamide [50-65-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	BRINP3 AGGF1 MECOM PRDM2 RPAP1 CD302 TACC1	1.38e-04	195	131	7	1498_DN
Drug	16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	MAP4K3 MBNL1 DOCK10 MLLT10 NID1 CD302 LIMCH1	1.38e-04	195	131	7	7509_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	SETD1A DAG1 ITGA2B MED1 NFIX WDFY3 BRWD1	1.38e-04	195	131	7	3755_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	KANSL1L HIPK2 SPART PMEL PDPN RBFOX1 NID1	1.38e-04	195	131	7	5569_UP
Drug	Benzbromarone [3562-84-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	KANSL1L KAT6A PRDM2 RPAP1 CD302 WDFY3 FBXW7	1.43e-04	196	131	7	5015_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; HL60; HT_HG-U133A	SETD1A MAP4 AGGF1 PRDM2 ITPR2 PTP4A3 VCAN	1.43e-04	196	131	7	1864_DN
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A	KAT6A HIPK2 ZNF280B ITPR2 NFIX TP63 LPP	1.43e-04	196	131	7	4291_UP
Drug	Famprofazone [22881-35-2]; Up 200; 10.6uM; HL60; HT_HG-U133A	MAP4 ZNF280B NUP214 PIK3C2G TP63 VCAN RBFOX1	1.43e-04	196	131	7	2174_UP
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	KANSL1L FRAS1 MAP4 MLXIP TP63 ZFHX2 NID1	1.43e-04	196	131	7	2250_UP
Drug	(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A	HIPK2 PRDM2 HSPA12A PTPRZ1 TP63 RBFOX1 NID1	1.43e-04	196	131	7	5533_UP
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; HL60; HT_HG-U133A	SETD1A STK17B HIPK2 CLEC7A RPAP1 ASCC2 NUMB	1.47e-04	197	131	7	2343_DN
Drug	Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; HL60; HG-U133A	MAP4 GIN1 BAG3 NUP214 PMEL LUZP1 HR	1.47e-04	197	131	7	1763_UP
Drug	Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A	HIPK2 MECOM NUP214 LUZP1 ITPR3 HSPA12A PTP4A3	1.47e-04	197	131	7	5512_UP
Drug	Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	MAP4 NUP214 LUZP1 PRDM2 PTP4A3 RPAP1 KLF5	1.47e-04	197	131	7	1674_DN
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; PC3; HT_HG-U133A	SETD1A STK17B ARHGAP26 MECOM ITGA2B MLXIP PTP4A3	1.47e-04	197	131	7	6688_UP
Drug	Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAP4 KAT6A AGGF1 MLLT10 LUZP1 KLF5 TACC1	1.52e-04	198	131	7	4837_DN
Drug	SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A	KANSL1L MAP4 ARHGAP26 DOCK10 HIPK2 MED1 NID1	1.52e-04	198	131	7	4977_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	HIPK2 PRDM2 PTP4A3 LPP ZFHX2 LIMCH1 WDFY3	1.52e-04	198	131	7	1002_UP
Drug	rotenone; Up 200; 1uM; PC3; HT_HG-U133A	ARHGAP26 DOCK10 PTP4A3 CELSR2 TP63 RBFOX1 HR	1.52e-04	198	131	7	5948_UP
Drug	Phenelzine sulfate [156-51-4]; Up 200; 17uM; MCF7; HT_HG-U133A	FRAS1 MECOM TP63 SETBP1 RBFOX1 NUMB HR	1.52e-04	198	131	7	3884_UP
Drug	Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	MAP4 KAT6A HIPK2 MLLT10 ITPR2 PTP4A3 PARM1	1.52e-04	198	131	7	5094_DN
Drug	Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A	ZNF280B NUP214 ITGA2B ITPR3 PTP4A3 VCAN ZFHX2	1.52e-04	198	131	7	4525_UP
Drug	novobiocin sodium, USP; Down 200; 100uM; MCF7; HG-U133A	SETD1A MAP4 ARHGAP26 LUZP1 ITPR2 TP63 SVIL	1.52e-04	198	131	7	342_DN
Drug	Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A	SETD1A HIPK2 NUP214 HSPA12A KLF5 ZFHX2 NID1	1.57e-04	199	131	7	6240_UP
Drug	15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	PRDM2 ITPR3 PTP4A3 VCAN TENM1 WDFY3 HR	1.57e-04	199	131	7	7494_DN
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A	MAP4 MLLT10 ITPR3 HSPA12A UBAP2L NUMB TACC1	1.57e-04	199	131	7	1683_DN
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	MAP4 STK17B SNUPN PRDM2 UBAP2L CLINT1 RPAP2	1.57e-04	199	131	7	5321_DN
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A	MFSD6 SPART MLLT10 UBAP2L SETBP1 PARM1 FBXW7	1.57e-04	199	131	7	4543_DN
Drug	trypanothione disulfide	DAG1 ITGA2B VCAN SETBP1 NID1 VCAM1	1.62e-04	140	131	6	CID000115098
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SETD1A MAP4 KAT6A PRDM2 PTP4A3 LPP ZFHX2	1.62e-04	200	131	7	1692_UP
Drug	Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A	KAT6A MLLT10 PTP4A3 LIMCH1 WDFY3 PARM1 FBXW7	1.62e-04	200	131	7	5782_DN
Disease	Leukemia, Myelocytic, Acute	ARHGAP26 MECOM NUP214 MLLT10 SETBP1 SVIL LPP	1.34e-05	173	132	7	C0023467
Disease	granulins measurement	CDH23 ITGA2B CELSR2	1.87e-05	12	132	3	EFO_0008141
Disease	Acute myeloid leukemia	NUP214 MLLT10 LPP	5.68e-05	17	132	3	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	NUP214 MLLT10 LPP	5.68e-05	17	132	3	601626
Disease	progranulin measurement	CDH23 ITGA2B CELSR2	1.27e-04	22	132	3	EFO_0004625
Disease	response to opioid	MUC16 CACNA2D4 TP63 RBFOX1	1.64e-04	61	132	4	EFO_0008541
Disease	Myelomonocytic leukemia	ARHGAP26 SETBP1	1.97e-04	5	132	2	C0027019
Disease	Acute Myeloid Leukemia, M1	MECOM NUP214 MLLT10 SVIL LPP	2.53e-04	125	132	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	MECOM NUP214 MLLT10 SVIL LPP	2.53e-04	125	132	5	C1879321
Disease	chronic obstructive pulmonary disease	SETD1A FRAS1 BAG3 DOCK10 MECOM RPAP1 SVIL RBFOX1 EPC1 ASCC2 DOT1L	2.76e-04	688	132	11	EFO_0000341
Disease	intellectual disability (implicated_via_orthology)	KANSL1L ZNF280B ITGA2B RBFOX1	3.64e-04	75	132	4	DOID:1059 (implicated_via_orthology)
Disease	QRS duration	ARHGAP24 CEP85L BAG3 ANKRD50 CACNA2D4 SETBP1 RBFOX1	4.02e-04	298	132	7	EFO_0005055
Disease	platelet reactivity measurement, thrombus formation measurement	SETBP1 SVIL	4.11e-04	7	132	2	EFO_0004985, EFO_0007615
Disease	cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant	RBFOX1 NID1	5.46e-04	8	132	2	EFO_0001062, EFO_0007044
Disease	acute myeloid leukemia (is_implicated_in)	KAT6A NUP214 MLLT10 LPP	5.60e-04	84	132	4	DOID:9119 (is_implicated_in)
Disease	nasopharyngeal neoplasm	MECOM MED1 RBFOX1 EPC1 TNFRSF19	6.03e-04	151	132	5	EFO_0004252
Disease	Cancer of Nasopharynx	MECOM TNFRSF19	7.00e-04	9	132	2	C0238301
Disease	Nasopharyngeal Neoplasms	MECOM TNFRSF19	7.00e-04	9	132	2	C0027439
Disease	Anemia, Sickle Cell	CAD VCAM1	8.73e-04	10	132	2	C0002895
Disease	renal cell carcinoma	CEP85L ITPR2 RBFOX1	8.84e-04	42	132	3	EFO_0000681
Disease	volumetric bone mineral density	MAP4K3 FHAD1 RBFOX1	8.84e-04	42	132	3	EFO_0007620
Disease	Adenoid Cystic Carcinoma	KAT6A VCAN ASPM FBXW7	1.08e-03	100	132	4	C0010606
Disease	Colorectal Carcinoma	CAD RPAP1 CD226 KLF5 TP63 SETBP1 TENM1 NID1 FBXW7 HR	1.26e-03	702	132	10	C0009402
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ITPR2 ITPR3	1.27e-03	12	132	2	DOID:1441 (implicated_via_orthology)
Disease	complement C1q tumor necrosis factor-related protein 1 measurement	CDH23 CELSR2	1.27e-03	12	132	2	EFO_0801493
Disease	mean corpuscular hemoglobin concentration	ATMIN DENND4A DAG1 MECOM PHGDH E2F8 ITPR2 SUSD1 CD226 UBAP2L RBFOX1 ASCC2 DOT1L	1.40e-03	1105	132	13	EFO_0004528
Disease	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	NUP214 MLLT10 FBXW7	1.74e-03	53	132	3	C1961099
Disease	Pneumoconiosis	CDH23 PTPRZ1	1.74e-03	14	132	2	C0032273
Disease	Bagassosis	CDH23 PTPRZ1	1.74e-03	14	132	2	C0004681
Disease	hair morphology measurement	ZCCHC8 MLXIP TNFRSF19	1.84e-03	54	132	3	EFO_0007821
Disease	white matter microstructure measurement	DAG1 MECOM MLLT10 VCAN SETBP1 WDFY3 SOS1	1.92e-03	390	132	7	EFO_0005674
Disease	lymphocyte:monocyte ratio	DOCK10 LPP CD302 VCAM1 KNL1 RPAP2	1.93e-03	288	132	6	EFO_0600088
Disease	acute graft vs. host disease, donor genotype effect measurement	AGGF1 RBFOX1	2.01e-03	15	132	2	EFO_0004599, EFO_0007892
Disease	Autosomal recessive primary microcephaly	ASPM KNL1	2.01e-03	15	132	2	cv:C3711387
Disease	RASopathy	ARHGAP26 SOS1	2.01e-03	15	132	2	cv:C5555857
Disease	platelet component distribution width	DOCK10 MECOM ITGA2B CD226 SVIL LPP EPC1 NUMB CLINT1 BRWD1	2.15e-03	755	132	10	EFO_0007984
Disease	Dermatitis	FLG VCAM1	2.29e-03	16	132	2	C0011603
Disease	primary autosomal recessive microcephaly (is_implicated_in)	ASPM KNL1	2.29e-03	16	132	2	DOID:0070296 (is_implicated_in)
Disease	prostate carcinoma, type 2 diabetes mellitus	UBAP2 MBNL1 KNL1	2.37e-03	59	132	3	EFO_0001663, MONDO_0005148
Disease	Adenocarcinoma of lung (disorder)	KSR2 KLF5 TP63 DOT1L SOS1	2.39e-03	206	132	5	C0152013
Disease	PROSTATE CANCER, HEREDITARY, 1	MBNL1 MECOM KNL1	2.49e-03	60	132	3	C4722327
Disease	Multiple congenital anomalies	TP63 SETBP1	2.58e-03	17	132	2	C0000772
Disease	Disorder of eye	FRAS1 CDH23 CACNA2D4 VCAN USH2A	2.70e-03	212	132	5	C0015397
Disease	electrocardiography	ARHGAP24 CEP85L BAG3 LUZP1 HMCN2 SETBP1 SVIL MANSC4	2.71e-03	530	132	8	EFO_0004327
Disease	Myeloid Leukemia	MECOM SETBP1	2.90e-03	18	132	2	C0023470
Disease	Leukemia, Monocytic, Chronic	MECOM SETBP1	2.90e-03	18	132	2	C0023466
Disease	cardiac troponin T measurement	TRABD2A BAG3 CDH23 MECOM RBFOX1	3.10e-03	219	132	5	EFO_0005043
Disease	cerebral infarction (is_marker_for)	BRINP3 SOS1	3.23e-03	19	132	2	DOID:3526 (is_marker_for)
Disease	Juvenile Myelomonocytic Leukemia	ARHGAP26 SETBP1	3.23e-03	19	132	2	C0349639
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	DOCK10 CDH23 GRIA4 HSPA12A CNTNAP5 UBAP2L SETBP1 RBFOX1 USH2A BRWD1	3.29e-03	801	132	10	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	Abnormality of refraction	SMG1 KSR2 GRIA4 ITPR2 CNTNAP5 RGS18 NFIX RBFOX1 ASCC2	3.35e-03	673	132	9	HP_0000539
Disease	MYELODYSPLASTIC SYNDROME	ARHGAP26 MECOM SETBP1	3.40e-03	67	132	3	C3463824
Disease	Vertigo	CDH23 PRDM2 SVIL LIMCH1	3.58e-03	139	132	4	HP_0002321
Disease	citrulline measurement	MECOM HMCN2	3.58e-03	20	132	2	EFO_0009777
Disease	alpha-tocopherol measurement	USH2A SOS1	3.58e-03	20	132	2	EFO_0007898
Disease	Prostate cancer, familial	MBNL1 MECOM KNL1	3.70e-03	69	132	3	C2931456
Disease	platelet crit	MFSD6 DOCK10 DAG1 MECOM ITGA2B ITPR2 CD226 NFIX SVIL NUMB DOT1L	3.73e-03	952	132	11	EFO_0007985
Disease	biological sex	BRINP3 ZCCHC8 CNTNAP5 RGS18 SETBP1	3.82e-03	230	132	5	PATO_0000047
Disease	Agents acting on the renin-angiotensin system use measurement	HIPK2 MECOM PTP4A3 CELSR2 SAP130 PCDH18	4.06e-03	335	132	6	EFO_0009931
Disease	Autosomal Recessive Primary Microcephaly	ASPM KNL1	4.33e-03	22	132	2	C3711387
Disease	Primary microcephaly	ASPM KNL1	4.33e-03	22	132	2	C0431350
Disease	pentachlorophenol measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022071
Disease	parathion measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022070
Disease	potassium chromate measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022072
Disease	mercuric chloride measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022068
Disease	heptachlor epoxide measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022067
Disease	methoxychlor measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022052
Disease	azinphos methyl measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022055
Disease	aldrin measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022054
Disease	dicofol measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022060
Disease	disulfoton measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022062
Disease	dieldrin measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022061
Disease	endrin measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022064
Disease	endosulfan measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022063
Disease	heptachlor measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022066
Disease	ethion measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022065
Disease	chlorpyrifos measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022057
Disease	cadmium chloride measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022056
Disease	diazinon measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022059
Disease	dibutyl phthalate measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0022058
Disease	environmental exposure measurement	MUC16 CNTNAP5 USH2A	4.33e-03	73	132	3	EFO_0008360
Disease	body weight	DMTF1 BRINP3 MBNL1 KSR2 MECOM SNUPN MLLT10 SPATA31C1 SUSD1 SETBP1 LPP RBFOX1 DOT1L	4.36e-03	1261	132	13	EFO_0004338

Protein segments in the cluster

Peptide	Gene	Start	Entry
CSNVPVSTINHAFSS	TACC1	536	O75410
STPSNNVHTSLSHVQ	ZNF280B	216	Q86YH2
FTQVHNLPESDSEST	C2orf16	1256	Q68DN1
HSPVNQFANTSETNT	EPC1	491	Q9H2F5
AVAAVSDQHATSPFD	BRINP3	31	Q76B58
QNFSDSSESDTHPFV	VCAN	1441	P13611
ADSLHTSFNIQVSPS	ADGRG4	1756	Q8IZF6
HSDSRFTTVFSTAPQ	CD302	196	Q8IX05
TVTAEAVSQASSHPE	ASCC2	431	Q9H1I8
STQAVTFSPSFHNQA	AKAP11	736	Q9UKA4
HFASNSQEPASALAT	AGGF1	166	Q8N302
SSTATAQTVPIDSFH	ANKRD50	1196	Q9ULJ7
AQTVPIDSFHNLSFT	ANKRD50	1201	Q9ULJ7
NVTDANTHRPVFQSS	CELSR2	701	Q9HCU4
SHVQSSPVQSDSSTA	FLG	3911	P20930
LHAQTVSQTAASSPQ	DOT1L	436	Q8TEK3
SENSPVSSFVAHVLA	CDH23	1861	Q9H251
QITHVSSADSPATVD	DMTF1	466	Q9Y222
HQAVFSQCPALQTSS	DISP2	1221	A7MBM2
SQIHFLSPDSFVNNS	ASPM	311	Q8IZT6
QDTLTHSSPSFNLDT	DENND4A	1296	Q7Z401
FVNQPHSSSQVSLGF	PIK3C2G	26	O75747
SDNSTSLQTHQPVFI	ITPR2	1496	Q14571
SSPFSENSTSLQTHQ	ITPR3	1481	Q14573
VTISSNHVPENFSLE	PCDH18	806	Q9HCL0
HSIFSPSLEEQTAVS	MECOM	641	Q03112
SESTAQQFSEPQHTQ	MUC16	521	Q8WXI7
NSVAVSASPTHENSV	MUC16	2006	Q8WXI7
PHQFITSTNTFTDVS	MUC16	4356	Q8WXI7
NTEAVHPSTNTAASN	MUC16	7171	Q8WXI7
STQEDTTVAISTPHF	MUC16	7216	Q8WXI7
HSATTQRFPQSVVTT	MUC16	9396	Q8WXI7
FTNISLVTHPAESSS	MUC16	11261	Q8WXI7
FTESDTPQTNVTHVT	MAP4K3	766	Q8IVH8
DAIVDFSSQHSTPSL	PARP15	426	Q460N3
HNPTDLFDSVTNNTR	PARP15	641	Q460N3
SHSNFTAVSNVNVLS	KANSL1L	736	A0AUZ9
ASALHFPSTSIIQQS	NFIX	366	Q14938
FETITDNTPFTSVNH	FRAS1	3241	Q86XX4
HVQVFSPHTLQSSAF	HIPK2	11	Q9H2X6
SVEALNSPHSESFVS	MAP4	191	P27816
VAVPAVTSADSQFSQ	LYSMD4	276	Q5XG99
DQNASTHTPQSSVKT	CLINT1	301	Q14677
APQVSIHTSSQHFSQ	HMCN2	606	Q8NDA2
FINSFGNASSIPTVH	KIAA2026	1966	Q5HYC2
PVHTEANFSANTLSV	KSR2	381	Q6VAB6
STPIQHSFLTDVSDV	CCDC28A	161	Q8IWP9
NGSHIPQTSSVFSIE	DAG1	141	Q14118
SSIPTDSSNHQVLEA	FETUB	156	Q9UGM5
VTQHFLSPETSALSA	HR	1136	O43593
PHVDNIETANSFAVT	GRIA4	66	P48058
ITTTENATHSTPNFT	MUC3A	2131	Q02505
SSQVPIVFENTDLHS	NID1	446	P14543
THSFGNPSISVSTQQ	LPP	26	Q93052
TEAPSSTTHQDLVVN	MANSC4	171	A6NHS7
LSSAVPSQSSIHSFD	NUP214	896	P35658
AYNLAPESTSESHSQ	KNL1	616	Q8NG31
TDSPNTAVSVHVSES	ACBD3	436	Q9H3P7
LSPSHIVNDTDSNVS	HSPA12A	36	O43301
SATSPHQSQQSTVDV	PRDM10	951	Q9NQV6
NNFSVQPTHTVSQAS	PTPRZ1	1121	P23471
SPTSSVTSENSEVFH	PTPRZ1	1596	P23471
PEVFSASVTTNHSST	PARM1	166	Q6UWI2
EETPTTTSHSQAFNF	MFSD6	421	Q6ZSS7
SFSVQEVQVDSSHLP	POLA1	316	P09884
NSSANSTETLQHVPS	TMEM123	46	Q8N131
QHVPSDHTNETSNST	TMEM123	56	Q8N131
VTTFSQSLHTAVPTA	POM121	896	Q96HA1
VIDFHNPSDSISITS	FKBP9	361	O95302
PSVSDHSQQVVDSGF	KAT6A	1536	Q92794
TLTHDAPATTFSQSQ	MLXIP	491	Q9HAP2
TSPYNTDHAQNSVTA	TP63	131	Q9H3D4
AVPFSLDSVANSIHS	ATP6AP2	101	O75787
PSFDSNTDVHTVASL	ARHGAP24	196	Q8N264
SFDSQVSLPISVHTQ	ATMIN	446	O43313
FSSVETQTSAEPHTV	ATMIN	806	O43313
SVQIEPVHTEAFSSS	FHAD1	1111	B1AJZ9
PVHTEAFSSSQEQQS	FHAD1	1116	B1AJZ9
LSPTHINATASETFT	CCDC150	16	Q8NCX0
STFVVSTVNTQDPHV	DOCK10	846	Q96BY6
TSSELTAVNFPSFHV	E2F8	681	A0AVK6
TNISESHPNATFSAV	IGHM	271	P01871
SNAHFSNLPVNTSIS	CACNA2D4	191	Q7Z3S7
HTFDSSSSQHPISTQ	GAB4	461	Q2WGN9
NSVTNSSSIVDLPVH	FBXW7	141	Q969H0
SLQTPFSEESVSHSQ	CEP85L	426	Q5SZL2
ENQLLPVSSSHTAQS	BRWD1	1696	Q9NSI6
PVSSSHTAQSNVDES	BRWD1	1701	Q9NSI6
LTSVSNHVSSPFELS	LUZP1	831	Q86V48
SATSVPFAATATANQ	MBNL1	356	Q9NR56
FANTHTAPATVVLVS	MARF1	436	Q9Y4F3
ESSQPNTSSHNISVI	GEN1	566	Q17RS7
QSDSFEAAVPSNSHI	CD226	126	Q15762
RFPSVTSNEHFSTAE	ERICH5	16	Q6P6B1
HTETQQPEATAAATS	BAG3	546	O95817
SSPVVVQHSVASQAS	CEP295	1101	Q9C0D2
DVNAVTTVHSSSDPF	CNTNAP5	1206	Q8WYK1
SESRFSVSFQHPVND	MED1	446	Q15648
NIELASSEPQHFTTT	LIMCH1	651	Q9UPQ0
TATNFTTHNIPQTFT	PRDM2	1316	Q13029
SPTFQANGTDSAFHV	NUMB	361	P49757
TPFIFEHTVNNSTAV	FNDC8	181	Q8TC99
AFSQISEHSVFTPTE	ARHGAP20	956	Q9P2F6
TESSHALNISTPQEA	USH2A	2041	O75445
THSEQSPADTSAQTV	RBFOX1	71	Q9NWB1
STLTLSPVSFENEHS	VCAM1	366	P19320
QAHDLSPAAESSSTF	SVIL	216	O95425
SESTVHAQEQSPSAT	PDPN	86	Q86YL7
HAQEQSPSATASNVA	PDPN	91	Q86YL7
SAVSFAFNVTHLEPT	GIN1	266	Q9NXP7
NNVTSPEFTSVQHGS	SMG1	111	Q96Q15
SFTAGTVFDNVHPSQ	ARHGAP26	776	Q9UNA1
LFHPEETSSSSQTQD	STK17B	301	O94768
VQAHPYSTTFQESAS	TEKT4	226	Q8WW24
STQDVQSSPHNQFTF	TENM1	176	Q9UKZ4
TSSAPFTINAHQSDI	WDR45	181	Q9Y484
QHSSLETTSRQPAFQ	SPATA3	56	Q8NHX4
SFSVSQDLNSTAAPH	SNUPN	11	O95149
HVSSQSLSFDSSNPE	ITGA2B	246	P08514
ASVVPHASENLASQV	SPATA31C1	891	P0DKV0
AHSSSAFTITDQVPF	PMEL	201	P40967
SPFHSSNDTVFIQVT	SOS1	1111	Q07889
HQQTEVSFSEPASDA	REELD1	471	A0A1B0GV85
TNESVPFAQHSSLDS	SETD1A	476	O15047
NQENVSHLSVSSASP	MLLT10	486	P55197
HTFSAQTAPTTDSLN	MLLT10	796	P55197
NHSQPTQSSLEDSVT	CLEC7A	91	Q9BXN2
SFSSAPQHAEVNGNT	SPART	131	Q8N0X7
PHSQASEANSFETSQ	UBAP2	301	Q5T6F2
EVPHGSQSSESFQFQ	ZCCHC8	451	Q6NZY4
ITHNPTNATLSTFIE	PTP4A3	21	O75365
GHETSIIPNSTAFQD	WDFY3	1486	Q8IZQ1
QTAISQPASGNTFSH	UBAP2L	321	Q14157
FSSSDQILSHDTSAP	ZFHX2	181	Q9C0A1
ITNSITQPTLHSFDA	RGS18	161	Q9NS28
HDSTFPLIDSSSQNQ	RPAP2	486	Q8IXW5
SHATSFNFTTREQVP	SUSD1	441	Q6UWL2
EVTTSHLANPNFTSN	THAP5	226	Q7Z6K1
APAATTVVQTHSQSA	SAP130	641	Q9H0E3
TVVQTHSQSASTNAP	SAP130	646	Q9H0E3
QPASSFQVETASQGH	XRN1	1661	Q8IZH2
LSHDSSQVPNFINAT	TRABD2A	266	Q86V40
HVNSFIFSQDPQSSD	RPAP1	1311	Q9BWH6
TSQNHGFAVETDSLP	CAD	291	P27708
ATSTSDPAQHLQLTQ	ZBTB24	661	O43167
HRDSIQSSDFSPTVN	WDR38	146	Q5JTN6
PVQSHSENFTAATDL	TNFRSF19	361	Q9NS68
VNAQALTSAFSPHTK	PHGDH	316	O43175
FSAETHSAASFPQQV	VSIG10L	181	Q86VR7
NVSSASNPENDSSHV	SETBP1	386	Q9Y6X0
QSLFHITASQPADSA	TRAV6	111	A0A075B6T7
NQFISSEPTALHSSE	ZBTB26	201	Q9HCK0
SFHSSPALENATITI	HSD52	36	Q0P140
SIFSSHQTAAPEVNN	KLF5	191	Q13887